baber/WOPTO huggingface dataset:
Patent JP-3136326-B2 (JP)
IPC: E04G21/16
Filed: 1993-03-10
Granted: 2001-02-19
Abstract: The invention relates to a device for lifting building elements, which elements are comprised of a resilient core portion (8) as well as of a surface layer (9, 9') covering it on both sides. The device is comprised of a frame structure (1), of at least one arm member (2) extending through the frame and movable relative to the frame, of a gripping member arranged at one end of the arm member and insertable under a surface layer on top of a core layer (8), of locking members arranged on the opposite end of the arm member (2) for locking the arm member (2) into a lifting position, as well as of members for supporting the frame structure (1) on a surface layer (9') opposite to the element to be lifted.
Patent JP-H0796251-B2 (JP)
IPC: B29C48/05
Filed: 1994-02-08
Abstract: PCT No. PCT/EP94/00361 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Feb. 8, 1994 PCT Pub. No. WO94/19169 PCT Pub. Date Sep. 1, 1994.The invention concerns a closable extrusion nozzle for thermoplastic materials, with a nozzle plate (4) containing nozzles permitting the extrusion of the thermoplastic material from a hopper (1) and with a perforated plate (7), disposed upstream of the nozzle plate, whose apertures (8) can be brought in and out of alignment with the nozzles by displacing the perforated plate (7) with respect to the nozzle plate (4). The nozzle plate (4), which is U-shaped in cross-section, with the arms of the U at right angles to the direction of displacement of the perforated plate, is designed as a housing for the perforated plate (7) enclosed within it. A sealing surface (15) on the perforated plate (7) rests against the flat housing floor (5) in which the nozzles (6) are located, there being a gap between the perforated plate (7) and the housing at least in the curved regions (16, 17) of the floor, and the region in which the seal is formed by the sealing surface (15) resting against the floor (5) being limited to a narrow zone round the nozzles (6).
Patent JP-3212094-B2 (JP)
IPC: A23P10/22
Filed: 1994-03-03
Granted: 2001-09-25
Abstract: PCT No. PCT/BE94/00019 Sec. 371 Date Dec. 4, 1995 Sec. 102(e) Date Dec. 4, 1995 PCT Filed Mar. 3, 1994 PCT Pub. No. WO94/19973 PCT Pub. Date Sep. 15, 1994The invention relates to an agglomerated composition comprising at least one fructan exhibiting instant colloidal dispersion. The invention also relates to a process for preparing the agglomerated composition, to a process for preparing a composition having a creamy structure using the said agglomerated composition, and to the creamy-structured composition thus obtained and the food products comprising the said compositions.
Patent JP-3805367-B2 (JP)
IPC: D21H17/29
Filed: 1996-03-26
Granted: 2006-08-02
Abstract: Paper sizing agent mixtures of: (A) finely divided aqueous dispersions of C14 to C22 alkyl diketenes obtainable by dispersing the alkyl diketenes in water in the presence of cationic starch with an amylopectin content of at least 95 wt.%, and (B) finely divided aqueous polymer dispersions forming a paper sizing agent, process for producing the paper sizing agent mixtures by mixing th e components (A) and (B) and the use of the paper sizing agent mixtures as mass and surface sizing agents for paper, pasteboard and cardboard.
Patent JP-3689115-B2 (JP)
IPC: B65D51/20
Filed: 1996-03-30
Granted: 2005-08-31
Abstract: The tin can is closed by a paper, plastic or metal-foil membrane (2) on at least one end face in such a way that the outer side of the foil edge region (5) raised in the direction of the can's axis (A) is joined to the essentially cylindrical inner surface of the wall of the can (1) to form a seal, without covering the wall edge of the can. The membrane foil (2) with the raised foil edge region (5) is introduced into the can and forced against the inner wall of the can (1) by a die (8) with an expandable periphery (17). Heat is then applied to create a sealing join between the raised foil edge region (5) and the inner wall of the can (1) without any external pressure-absorbing device.
Patent JP-4462455-B2 (JP)
IPC: B01D53/18
Filed: 1998-02-03
Granted: 2010-05-12
Abstract: An open contact reactor is in the form of a tank (1), in which a plurality of spray nozzles (2) for spraying finely divided liquid are arranged and through which a gas is to be conducted in a main gas flow direction (P) in order to be contacted with the finely divided liquid, the spray nozzles (2) being arranged on different nozzle levels (L1, L2, L3) spaced apart in the main gas flow direction, and the spray nozzles (2) on each level being substantially uniformly distributed over the cross section of the tank. A gas guiding member (3), which extends along the circumference of the tank (1) and is adapted to guide the gas flow closest to the wall of the tank towards the interior of the tank essentially perpendicular to the main gas flow direction (P), is arranged between the levels in at least one pair of juxtaposed nozzle levels (L1-L2, L2-L3). The guiding member (3) extends into the tank (1) to a distance from the wall thereof, which over the major part of the circumference of the wall at each point is 10-90 % of the distance between, the nozzle (2) positioned closest to the respective point and the wall.
Patent ES-2402724-B2 (ES)
Title: Modelo dental anatómico diferenciado para el estudio de la anatomía dental y gingival
Inventor: ALVARO GARCIA JOSE ANTONIO
IPC: A61C13/00
Filed: 2011-10-31
Granted: 2014-01-20
Abstract: Modelo dental anatómico diferenciado para el estudio de la anatomía dental y gingival que se caracteriza por presentar unos dientes con su anatomía completa y por ser éstos extraíbles de la encía. Dado que tanto las encías como los dientes están elaborados en material plástico rígido y la anatomía radicular presenta curvaturas anatómicas retentivas, este modelo presenta un material elástico, en el interior de las encías, que permite el posicionamiento y la desinserción de los dientes de las mismas aunque tengan éstos una anatomía radicular retentiva. Para facilitar el aprendizaje de la anatomía dental y gingival y para apreciar con mayor precisión los detalles anatómicos, este modelo está aumentado de 4 a 4,5 veces del tamaño natural. Su principal uso será como modelo didáctico e incluso, como juguete.
Patent IE-S86397-B2 (IE)
Title: Valve for central heating and domestic hot water system
Inventor: O'BYRNE MICHAEL
IPC: F16K21/00
Filed: 2013-05-13
Abstract: The present invention relates to a valve for use in central heating and domestic hot water 10 systems, to control the flow of water in the circuits of such systems. In particular the invention provides a valve comprising a valve body of the rotary type and an electrical valve actuator the salient elements of which are an electrical motor, an electrical latch, an electrical switch and interconnecting circuitry terminating in a pair of electrical terminals, the application of a voltage to said terminals serving to energise the motor thus driving the valve to its open state, to latch the valve in said open state and to de-energised the motor. The advantage of the invention is improved longevity of the actuator motor compared to actuators which use the motor to both drive the valve to its open state and to hold the valve in said open state. <Figure 1>
Patent AU-2002243221-B2 (AU)
Title: Methods and devices for the quantitative detection of prostate specific membrane antigen and other prostatic markers
Inventor: WRIGHT GEORGE L JR
IPC: C12Q1/6886
Filed: 2001-11-16
Granted: 2006-11-09
Abstract: The invention provides for the detection and quantification of PSMA, PSMA', and other prostatic markers in serum samples as well as in other types of samples for use in differentiating prostate cancer, benign prostatic hyperplasia, and negative diagnoses. The diagnostic detection of nucleic acids, such as mRNAs, which encode prostatic markers in cell lysates and other sample sources is also provided. In addition to the multiplexed detection/quantification of these protein- and nucleic acid-based markers, the invention also includes biochips, kits and integrated systems.
Patent AU-2002363141-B2 (AU)
Title: A peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis
Inventor: SURUJBALLI OM P
IPC: C07K14/35
Filed: 2002-10-31
Granted: 2006-06-29
Abstract: The present invention provides an assay for detection of M. bovis-infected animals. A tracer, comprising a peptide of M. bovis protein MPB70 conjugated to a fluorophore, is added to a serum sample from an animal to form a mixture. The fluorescence polarization of the mixture in then measured and compared to the fluorescence polarization of a control. The present invention further provides a tracer for use in fluorescence polarization assay to detect antibodies specific for M. bovis. The tracer comprises a peptide of M. bovis protein MPB70 conjugated to a fluorophore, such that the tracer is able to bind to antibodies specific for M. bovis to produce a detectable change in fluorescence polarization.
Patent AU-2003241580-B2 (AU)
Title: Anti-IGF-I receptor antibody
Inventor: TAVARES DANIEL J
IPC: A61K39/395
Filed: 2003-06-12
Granted: 2009-11-19
Abstract: DNAs, vectors, host cells and genetic constructs of antibodies, humanized antibodies, resurfaced antibodies, antibody fragments, derivatized antibodies, and conjugates of these molecules with cytotoxic agents, which specifically bind to and inhibit insulin-like growth factor-I receptor, antagonize the effects of IGF-I and are substantially devoid of agonist activity toward the insulin-like growth factor-I receptor. These molecules can be conjugated to cytotoxic agents for use in the treatment of tumors that express elevated levels of IGF-I receptor, such as breast cancer, colon cancer, lung cancer, ovarian carcinoma, synovial sarcoma and pancreatic cancer. These molecules can also be labeled for in vitro and in vivo diagnostic uses, such as in the diagnosis and imaging of tumors that express elevated levels of IGF-I receptor.
Patent AU-2003287463-B2 (AU)
Title: Botulinum toxin formulations for oral administration
Inventor: DONOVAN STEPHEN
IPC: A61K9/19
Filed: 2003-11-03
Granted: 2008-01-17
Abstract: Pharmaceutical compositions of a botulinum toxin for oral administration to a patient with a gastrointestinal disorder.
Patent AU-2004203593-B2 (AU)
Title: Agitator mill
Inventor: GERL STEFAN
IPC: B02C17/16
Filed: 2004-08-04
Granted: 2009-02-19
Abstract: Grinding stock is removed by the suction with the aid of a device (32) for separating the stock from the grinding bodies (37). The separator device comprises an immersion nozzle (32) with an inlet opening located in the bed of stock and grinding bodies. The nozzle is connected to a suction device (40) via a suction pipe (39) located above the grinding vessel (1). The grinding vessel is a vertically oriented one with a closed base (3) and a cover (16) on top. An agitator (11) inside the vessel extends parallel to the vessel length axis and is provided with stirrers (13). A drive device (19) is used to rotate the agitator about its length axis. The grinding region (34) is partially filled with grinding bodies.
Patent AU-2004312213-B2 (AU)
Title: Enzymatic Treatment of Oils
Inventor: KRISTENSEN ANNA CECILIE JENTOFT
IPC: C12N9/14
Filed: 2004-12-23
Granted: 2010-03-11
Abstract: The present invention relates to a method of reducing and/or removing diglyceride from an edible oil, comprising a) admixing an edible oil with an acyl acceptor substrate and a fatty-acid CoA independent diglyceride: glycerol acyltransferase, wherein the fatty-acid CoA independent diglyceride: glycerol acyltransferase is characterized as an enzyme which in an edible oil is capable of transferring an acyl group from a diglyceride to glycerol. Preferably, the diglyceride: glycerol acyltransferase comprises the amino acid sequence motif GDSX, wherein X is one or more of the following amino acid residues L, A, V, I, F, Y, H, Q, T, N, M or S. Furthermore the present invention relates to the use of a fatty-acid CoA independent diglyceride: glycerol acyltransferase characterized as an enzyme which in an edible oil is capable of transferring an acyl group from a diglyceride to glycerol, in the manufacture of an edible oil, for reducing and/or removing (preferably selectively reducing and/or removing) diglyceride from said edible oil, and to the use of said enzyme in the manufacture of a foodstuff comprising an edible oil for improving the crystallization properties of said foodstuff.
Patent AU-2005253999-B2 (AU)
Title: Systems and methods for sling delivery and placement
Inventor: BRIAN MACLEAN
IPC: A61F2/00
Filed: 2005-06-09
Granted: 2011-07-14
Abstract: The invention, in various embodiments, is directed to systems, devices, and methods relating to pre-pubic approaches to delivering a supportive sling to periurethral tissue of a patient. The sling delivery system comprises a delivery device (300) having a conical tip(304) and a constant outside diameter of less than about 0.63 cm. The shaft (302) extends distably between about 17 and about 23cm. Preferably the system comprises a pusher assembly (330) slidably fifted over the shaft. The sling (102) may include a protective sleeve (104) for covering preferably including a gap (110) exposing a portion of the supportive sling.
Patent AU-2005280749-B2 (AU)
Title: Mechanical air fuel ratio regulating carburettor with fuel pressure regulation
Inventor: JOHN WILLIAMS ANTHONY
IPC: F02M7/22
Filed: 2005-08-18
Granted: 2011-09-22
Abstract: Described is a carburettor (8), comprising an air (2) inlet with a mechanically adjustable air valve (3), an into the air inlet coming mechanically adjustable atomiser, and a mechanical metering device connected with the air valve and the atomiser, maintaining a stoichiometric ratio between amounts of air and fuel. Furthermore the carburettor has fuel pressure regulating means/devices (13) that are equipped to influence the fuel pressure, in dependence of one or more dynamic engine load parameters, under which the vacuum signal in the air inlet, which is obtained via a vacuum intake conduit (12) coming into the air inlet (2). By regulating the fuel pressure also in dependence of the measured vacuum signal, the emission of unburned fuel is reduced under certain dynamic conditions of the combustion engine.
Patent AU-2005285222-B2 (AU)
Title: Liver stromal cells for prevention and treatment of immune responses in transplantation
Inventor: MCINTOSH KEVIN R
IPC: A61K39/00
Filed: 2005-09-08
Granted: 2013-01-17
Abstract: The present invention encompasses methods and compositions for reducing an immune response to a transplant in a recipient by treating said recipient with an amount of liver stromal cells effective to reduce or inhibit host rejection of the transplant. Also disclosed is a method of inducing a reduced immune response against a host by foreign tissue, i.e., graft versus host disease, by treatment with liver stromal cells.
Patent AU-2005305165-B2 (AU)
Title: Post-foaming dental mousse and methods utilizing the same
Inventor: CURTIS JOHN P
IPC: A61Q11/00
Filed: 2005-10-28
Granted: 2011-07-07
Abstract: A post foaming oral care mousse is provided by the invention. The mousse includes at least a dentifrice composition and a compressed liquid propellant having a boiling point less than -10°C. The liquid propellant is blended into the mousse as an emulsion, and the emulsion is adapted to be dispensed from a container as a gel that foams after a time delay. The mousse has a viscosity of less than 30,000 centipoise when measured prior to the addition of the propellant. Preferably, the mousse expands at least 100 vol % in less than 5 seconds upon exposure to atmospheric pressure.
Patent AU-2005326708-B2 (AU)
Title: Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
Inventor: DANIELSON MICHAEL E
IPC: C07D471/02
Filed: 2005-12-29
Granted: 2012-03-15
Abstract: Substituted fused [1,2]imidazo[4,5-] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a -CH(-R)- group in the fused ring at the 1-position of the imidazo ring, wherein R includes a functional group, for example, an amide, sulfonamide, urea, carbamate, ester, ketone, ether, a thio analog of the forgoing, sulfone, oxime, or hydroxylamine, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
Patent AU-2006221969-B2 (AU)
Title: Process for the manufacture of cellulose sulfate with improved characteristics
Inventor: FISCHER STEFFEN
IPC: C08B7/00
Filed: 2006-03-10
Granted: 2011-05-26
Abstract: The invention refers to a method for the production of cellulose sulfate which is completely water-soluble and has an adjustable solution viscosity in aqueous solution, which qualifies the produced sodium cellulose sulfate (SCS) as auxiliary material with ideal biological compatibility for biological and medical applications, in particular it is suitable for the encapsulation and immobilization of biological objects, e.g. tissue, cells, microorganisms, enzymes or viruses in microcapsule.
Patent AU-2006268183-B2 (AU)
Title: Glutamate aggrecanase inhibitors
Inventor: SUM PHAIK-ENG
IPC: C07C323/41
Filed: 2006-07-11
Granted: 2012-08-09
Abstract: The present invention relates to compounds of the formula (I), which are modulators of metalloproteinase activity. and pharmaceutically acceptable salts thereof, wherein W is -C(O)-, -OC(O)-, -NHC(O)-, -C(O)O-, Or -C(O)NH-; Ris phenyl, heteroaryl, biphenyl, bicyciic aryi, tricyclic aryl, bicyclic heteroaryl. or tricyclic heteroaryl, each optionally substituted with one or more of R or R, and when Ri is substituted with more than one of R or Re, the substituents can be identical or different; Ris hydrogen, (C -C) alkyl, (C-C) alkenyl, (C-C) alkynyl, -(CH)R , -OH, or -0-(C-C) alkyl; R is -COH, -CONH, -CONHOH, -CONHSOR, tetrazole, -SONHR, -SOH, -PO(OH)NH, -PO(OH)OR, -CONHR, -COOR, an acid mimetic group, or a 5 or 6-membered heterocycloalkyl or heteroaryl containing 1 to 4 heteroatoms selected from O, N, S; R is -COH, -CONH, -(CH)OR, or -CONRR;
Patent AU-2006308766-B2 (AU)
Title: Multifaceted tracker device for computer-assisted surgery
Inventor: JUTRAS SEBASTIEN
IPC: A61B19/00
Filed: 2006-11-02
Granted: 2012-04-12
Abstract: A tracker device (10,10',10") of the type associated with a surgical instrument and being trackable in space by a CAS system (100) such that a position of the surgical instrument is calculable. A support (12) is adapted to be connected to the surgical instrument. Optical elements are mounted to the support (12) in a first pattern (44A) so as to be detectable by the CAS system along a first range of visibility. Other optical elements are mounted to the support in a second pattern (44B,44C) so as to be detectable by the CAS system along a second range of visibility, with the first range of visibility and the second range of visibility having at most a common portion, whereby a position of the surgical instrument is tracked within the first and the second range of visibility as a function of the detection of any one of the patterns (44A,44B,44C) of the optical elements.
Patent AU-2007225879-B2 (AU)
Title: Fixed codebook searching device and fixed codebook searching method
Inventor: EHARA HIROYUKI
IPC: G10L19/107
Filed: 2007-03-08
Granted: 2011-03-24
Abstract: A fixed codebook searching apparatus which slightly suppresses an increase in the operation amount, even if the filter applied to the excitation pulse has the characteristic that it cannot be represented by a lower triangular matrix and realizes a quasi-optimal fixed codebook search. This fixed codebook searching apparatus is provided with an algebraic codebook (101) that generates a pulse excitation vector; a convolution operation section (151) that convolutes an impulse response of an auditory weighted synthesis filter into an impulse response vector that has a value at negative times, to generate a second impulse response vector that has a value at second negative times; a matrix generating section (152) that generates a Toeplitz-type convolution matrix by means of the second impulse response vector; and a convolution operation section (153) that convolutes the matrix generated by matrix generating section (152) into the pulse excitation vector generated by algebraic codebook (101).
Patent AU-2007235421-B2 (AU)
Title: A purchase-transaction-settled online consumer referral and reward service using real-time specific merchant sales information
Inventor: WANG LEE
IPC: G06Q40/00
Filed: 2007-04-02
Granted: 2013-03-14
Abstract: A purchase-transaction-settled online consumer referral and reward system and method using real-time specific merchant sales information is provided. The system offers merchants a one-stop place for freely publishing of their real-time and specific sales offers and offers a risk-free service to merchants to use, who will be charged only after a referred purchase occurs and a revenue income is made. The system also allows merchants to determine how much they pay to the service provider for each referred purchase transaction, based on their profit margin and market competitiveness and the system serves all merchants, online or offline, big or small, and regardless of buy, sell, and payment settlement technologies in use. The system also offers consumers a one-stop place for finding matching sales offers specifically meeting their needs, refers consumers to merchants to buy at existing merchant establishments and rewards consumers with each purchase transaction led from the service provider.
Patent AU-2007240442-B2 (AU)
Title: Inhibitors of c-fms kinase
Inventor: WILSON KENNETH
IPC: A61P13/00
Filed: 2007-04-18
Granted: 2012-09-06
Abstract: The invention is directed to compounds of Formula (I): Formula (I), wherein Z, X, J, R and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula (I), are also provided.